Ever since the transdifferentiation of bone marrow cells (BMCs) into hepatocytes was documented [1][2], BMC has been an attractive cell source in regenerative medicine. MR imaging appears most promising for dynamically monitoring in vivo cell migration after magnetically labeled cell transplantation [3]. It is not clear, however, whether systemically administered mesenchymal stem cells (MSCs) labeled with superparamagnetic iron oxide nanoparticles can also transdifferentiate into hepatocytes. We built a new in vivo model for monitoring the transdifferentiation of magnetically labeled green fluorescent protein (GFP) positive MSCs into albumin-positive hepatocytes, under the specific "niche" made by CCl4 induced persistent liver damage. We also tracked magnetically labeled MSCs by using magnetic resonance (MR) imaging in vivo in mice. METHODS MSCs were isolated from GFP transgenic C57BL/6 mice and labeled with home synthesized superparamagnetic particles Fe 2 O 3 -PLL [4]. The liver damage model was established by injection of 0.5 ml/kg of carbon tetrachloride (CCl 4 ) into the peritoneum of Balb/c nude mice twice a week for five weeks. One day after the second injection, cell transplantation was performed by injection of 1× 10 6 MSC S via the caudal tail vein. Thirty-two recipient nude mice were randomly divided into five groups, three with and two without liver damage. Liver damage groups included mice injected with magnetically labeled GFP-positive MSCs (group A, n=8), GFP-positive MSCs (group B, n=8), or saline alone (group C, n=8). Control groups included mice injected with magnetically labeled GFP-positive MSCs (group D, n=4) and mice without injection (group E, n=4). MR examinations were performed 24 hours and 4 weeks after cell injection in groups A, B, and C. Liver signal-to-noise ratios (SNRs) on T2*-weighted MR images were measured. In all groups, serum albumin levels were analyzed four weeks post-injection, and the mice were then sacrificed for histologic tissue examination. Hematoxylin-eosin staining and Masson staining were performed to confirm liver damage. To assess the injected cells, consecutive slides were analyzed about both GFP and iron expressing. Cells expressing GFP were analyzed by both fluorescent microscopy and immunofluorescence with anti-GFP antibody. Cells expressing iron were assessed by Prussian blue staining. To determine whether injected cells differentiated toward hepatocytes, fluorescence immunohistochemistry analysis was performed with anti-albumin antibody, and albumin-positive cells ratios in GFP-positive cells were calculated. RESULTS GFP-positive MSCs could be effectively labeled with approximately 95% efficiency. Migration of transplanted labeled cells to the liver was successfully documented with in vivo MR imaging. SNRs on T2*-weighted images decreased significantly in the liver 24 hours after injection of MSCs (p < .05) and returned to the level achieved without labeled cell injection in 4 weeks (Fig.A-C, N ) . For groups A-E, serum albumin levels (g/l) were 20.0 ± 6.7, 20.3 ± 9.2, 18.0 ± 2.2, 34.5 ± 5.8, and 31.5 ± 5
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Fig.A-C: T2*-weighted MR images of Balb/c mouse 24 hours (A), 4 weeks (B) after injection of 1× 10
6 magnetically labeled GFP-positive MSCs, as well as one mouse at 24 hours after injected GFP-positive MSCs (C). Note the decrease and return of SI compared with SI in control mouse. Okamoto R et al. Nat Med 2002; 8: 1011-7 (2) Korbling M et al. N Engl J Med 2002; 346:738-46 
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